HomeAuthorsPosts by Sam Atkinson

Sam Atkinson

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge in profit for the third quarter ended May 31, 2026. This performance marks a decisive shift from a period of recovery toward a new phase of resilient growth in the...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the country grapples with a growing burden of non-communicable diseases (NCDs), particularly diabetes and chronic kidney disease. Recent estimates show that one-in-six Malaysians has diabetes, while one-in-seven is at risk of chronic...
spot_img

Keep exploring

SGX-LISTED COMPANIES

Hoe Leong Grows Profit Despite Falling Revenue In FY2025

https://open.spotify.com/episode/2DUSG1G2sp1CrZAbBagQaB?si=aaa51bac1310477a Revenue Down, Profits Up: 5 Surprising Realities from Hoe Leong’s 2025 Financial Turnaround In the...
SGX-LISTED COMPANIES

Centurion Corporation Just Unlocked A Massive Growth Secret In FY2025

https://open.spotify.com/episode/6ugUgKpfbuCo49DZfJw26b?si=fc648062786c48a2 The $2.7B Shift: 5 Surprising Truths Behind Centurion’s FY2025 Evolution Introduction: The Quiet Giant of...
SGX-LISTED COMPANIES

Vietnam’s Massive Economic Boom Saves Jardine Cycle & Carriage’s FY2025

https://open.spotify.com/episode/3k6XGAsQgKCELTMuXKoCOB?si=930ffe0ca97f4309 The Art of the Regional Hedge: How Jardine Cycle & Carriage Navigated the Southeast...
SGX-LISTED COMPANIES

Why Q & M Dental Is Aggressively Expanding Despite A 35% Bottom-Line Dip In FY2025

https://open.spotify.com/episode/0T0lgGE0YOpVf9BPYLy2w2?si=dfeecf16edc8405e A New Era for Regional Healthcare For the discerning financial analyst, Q & M Dental...
SGX-LISTED COMPANIES

AsiaMedic’s Profit Leaps S$2M In FY2025

https://open.spotify.com/episode/1oB8lD7OtLPm9wbAakzgJw?si=38966f7056814864 The Power of Focus: 5 Surprising Takeaways from AsiaMedic’s S$2M Profit Leap In the complex...
SGX-LISTED COMPANIES

How GSS Energy’s 58% Revenue Surge Masks An Industrial Identity Crisis – FY2025

https://open.spotify.com/episode/3HHeZxBQdkY5qOzKoIzXoa?si=10031d6ea827419e The Illusion of Performance In industrial manufacturing, a 58.66% year-on-year revenue surge is typically the...
SGX-LISTED COMPANIES

LS 2 Holdings Boosts FY2025 Cleaning Profits

https://open.spotify.com/episode/4HSzKIcMcQ6Y9F2mvLNr0t?si=cae0bd3668b84789 More Than Just Sweeping Floors: 4 Surprising Takeaways from LS 2 Holdings’ FY25 Results In...
SGX-LISTED COMPANIES

Avarga Said Goodbye To Its Paper Mill In FY2025

https://open.spotify.com/episode/5n3Nuj5BPlLDLcrOakioKZ?si=03560443251e4a75 From Paper Mills to $100M Paydays: The 4 Most Surprising Moves in Avarga's 2025...
SGX-LISTED COMPANIES

Inside Jadason Enterprises $2.5 Million Turnaround In FY2025

https://open.spotify.com/episode/3T96SDEr00y72J4HBRD4SV?si=7dcd01a939734673 Introduction: The Art of the Corporate Comeback Steering a company from a deep operational loss...
SGX-LISTED COMPANIES

How City Developments Tripled Profits In FY2025

https://open.spotify.com/episode/1QIw0KqIt9MndVfBDgJ9bq?si=ab425a905ba54eb7 The Asset-Light Coup: Inside CDL’s $2 Billion Capital Recycling Masterclass The 2025 fiscal landscape was...
SGX-LISTED COMPANIES

How Olam Group Re-Engineered Its Future With A 414% Profit Pivot In FY2025

https://open.spotify.com/episode/0kbI1OqIaESizNrTLHvcMP?si=8f1c0cd5aef5490e In the high-stakes theater of global commodities, 2025 was a year characterized by what...
SGX-LISTED COMPANIES

How Soilbuild Construction Achieved A Record-Breaking FY2025

https://open.spotify.com/episode/021GTljObhZ0e7ptaKUcaJ?si=86dae7a57d8e4743 Beyond Bricks and Mortar: 5 Takeaways from Soilbuild’s Record-Breaking Year The 50-Year "Overnight Success" In the...
Load more

Latest articles

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
Pharmaceutical

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...
Pharmaceutical

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...